Sign inGet started

Tubridy Karen L

Insider CIK 1589888 · EBIO Chief Development Officer · AKBA SVP, Chief Development Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AKBA Akebia Therapeutics, Inc. A Award deriv2020-02-282020-03-0285,000— $085,000SEC↗
AKBA Akebia Therapeutics, Inc. A Award2020-02-282020-03-0230,000— $088,133SEC↗
AKBA Akebia Therapeutics, Inc. S Sale2020-02-282020-03-023,454$8.70 $30.0K84,679SEC↗
AKBA Akebia Therapeutics, Inc. D To issuer2019-04-112019-04-126,075$7.70 $46.8K55,324SEC↗
AKBA Akebia Therapeutics, Inc. A Award deriv2019-02-282019-03-0545,000— $045,000SEC↗
AKBA Akebia Therapeutics, Inc. A Award2019-02-282019-03-0530,000— $061,399SEC↗
AKBA Akebia Therapeutics, Inc. F Tax w/h2018-12-122018-12-1311,928$8.94 $106.6K30,229SEC↗
AKBA Akebia Therapeutics, Inc. A Award deriv2018-02-282018-03-0225,000— $025,000SEC↗
AKBA Akebia Therapeutics, Inc. A Award2018-02-282018-03-0217,500— $041,518SEC↗
AKBA Akebia Therapeutics, Inc. A Award deriv2017-02-212017-02-2336,500$10.14 $370.1K36,500SEC↗
AKBA Akebia Therapeutics, Inc. A Award2017-02-212017-02-2323,000— $023,000SEC↗
AKBA Akebia Therapeutics, Inc. A Award deriv2016-11-302016-12-02130,000— $0130,000SEC↗
EBIO Eleven Biotherapeutics, In A Award deriv2016-07-092016-07-1213,328— $026,672SEC↗
EBIO Eleven Biotherapeutics, In S Sale2016-06-272016-06-294,372$2.08 $9.1K32,753SEC↗
EBIO Eleven Biotherapeutics, In A Award deriv2016-06-152016-06-1713,344— $013,344SEC↗
EBIO Eleven Biotherapeutics, In A Award deriv2016-02-252016-02-2940,000— $040,000SEC↗
EBIO Eleven Biotherapeutics, In A Award deriv2016-02-252016-02-2960,400— $060,400SEC↗
EBIO Eleven Biotherapeutics, In S Sale2015-12-282015-12-304,427$2.85 $12.6K32,973SEC↗
EBIO Eleven Biotherapeutics, In A Award2015-06-262015-06-2937,400— $037,400SEC↗
EBIO Eleven Biotherapeutics, In A Award deriv2015-02-262015-02-2765,000— $0150,827SEC↗